CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Gefitinib

Last Updated: December 22, 2003
Result type: Reports
Project Number: S0003
Product Line: Common Drug Review

Generic Name: Gefitinib

Brand Name: Iressa

Manufacturer: AstraZeneca

Indications: Cancer, Lung , non-small cell

Submission Type: New

Project Status: Complete

Date Recommendation Issued: June 23, 2004

Recommendation Type: Do not list